Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Montalban
J Rio

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 17, 2002
Primary progressive multiple sclerosisX Montalban, J Rio
Journal of the Neurological Sciences|April 22, 2006
Interferons and cognitionX Montalban, J Rio
Clinical and Experimental Immunology|February 6, 2013
Cellular immune responses in multiple sclerosis patients treated with interferon-betaM F Bustamante, J Rio, Z Castro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 1998
Lack of association between hepatitis G virus and multiple sclerosisS Sauleda, J Rio, X Montalban, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1996
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosisC Nos, M Comabella, M Tintoré, et al.
Journal of the Neurological Sciences|March 27, 2007
MS treatment: postmarketing studiesX Montalban
AJNR. American Journal of Neuroradiology|December 10, 1999
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR imagesA Rovira, J Alonso, G Cucurella, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2009
Plasma chitotriosidase activity in multiple sclerosisM Comabella, C Domínguez, J Rio, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2011
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosisJ E Martínez-Rodríguez, M López-Botet, E Munteis, et al.
Neurologia (Barcelona, Spain)|July 3, 2003
[Mitoxantrone]I Pericot, X Montalban
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 17, 2002
Primary progressive multiple sclerosisX Montalban, J Rio
Journal of the Neurological Sciences|April 22, 2006
Interferons and cognitionX Montalban, J Rio
Clinical and Experimental Immunology|February 6, 2013
Cellular immune responses in multiple sclerosis patients treated with interferon-betaM F Bustamante, J Rio, Z Castro, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 7, 1998
Lack of association between hepatitis G virus and multiple sclerosisS Sauleda, J Rio, X Montalban, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 1, 1996
High dose intravenous immunoglobulin does not improve abnormalities in the blood-brain barrier during acute relapse of multiple sclerosisC Nos, M Comabella, M Tintoré, et al.
Journal of the Neurological Sciences|March 27, 2007
MS treatment: postmarketing studiesX Montalban
AJNR. American Journal of Neuroradiology|December 10, 1999
Evolution of multiple sclerosis lesions on serial contrast-enhanced T1-weighted and magnetization-transfer MR imagesA Rovira, J Alonso, G Cucurella, et al.
Clinical Immunology (Orlando, Fla.)|January 30, 2009
Plasma chitotriosidase activity in multiple sclerosisM Comabella, C Domínguez, J Rio, et al.
Clinical Immunology (Orlando, Fla.)|October 14, 2011
Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosisJ E Martínez-Rodríguez, M López-Botet, E Munteis, et al.
Neurologia (Barcelona, Spain)|July 3, 2003
[Mitoxantrone]I Pericot, X Montalban
Pageof 21